LUCD Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
1.5M
+17.4%
1.3M
-16.5%
1.5M
+24.2%
1.2M
+4.1%
1.2M
Cost of Revenue
1.4M
-11.1%
1.6M
-12.6%
1.9M
+9.6%
1.7M
+8.6%
1.6M
Gross Profit
29.0K
+107.9%
-369000
-3.7%
-356000
+26.7%
-486000
-21.5%
-400000
Operating Expenses
12.8M
+9.2%
11.7M
-14.0%
13.7M
+21.1%
11.3M
+2.6%
11.0M
R&D
1.2M
-1.2%
1.2M
-30.0%
1.7M
+35.5%
1.3M
+1.4%
1.3M
SG&A
11.5M
+10.5%
10.4M
-11.8%
11.8M
+19.5%
9.9M
+2.8%
9.6M
Operating Income
-12801000
-5.7%
-12114000
+13.5%
-14011000
-19.2%
-11759000
-3.3%
-11384000
EBITDA
-12577000
-5.8%
-11892000
+15.3%
-14036000
-24.2%
-11305000
-1.3%
-11162000
Net Income
-11687000
+16.0%
-13909000
+14.5%
-16266000
-56.4%
-10397000
-134.2%
-4439000
EPS (Basic)
$-0.08
+52.9%
$-0.17
-41.7%
$-0.12
-20.0%
$-0.10
-25.0%
$-0.08
EPS (Diluted)
$-0.08
+52.9%
$-0.17
-41.7%
$-0.12
-20.0%
$-0.10
-25.0%
$-0.08
Shares (Diluted)
183.1M
+30.7%
140.1M
+6.3%
131.8M
+21.9%
108.2M
+9.3%
99.0M
Lucid Diagnostics (LUCD) โ€” Financials